Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Not applicable Interventional

The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension

ClinicalTrials.gov ID: NCT03614260

Public ClinicalTrials.gov record NCT03614260. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 2:04 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT03614260
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Not applicable
Lead sponsor
ReCor Medical, Inc.
Industry
Enrollment
225 participants

Conditions and interventions

Interventions

  • Paradise Renal Denervation System Device
  • Renal Angiogram Procedure

Device · Procedure

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 13, 2018
Primary completion
Dec 20, 2022
Completion
Jun 30, 2027
Last update posted
Apr 3, 2025

2018 – 2027

United States locations

U.S. sites
28
U.S. states
22
U.S. cities
27
Facility City State ZIP Site status
Cardiology PC Birmingham Alabama 35211
Cedars Sinai Medical Center Los Angeles California 940048
Bridgeport Hospital Bridgeport Connecticut 06610
Stamford Hospital Stamford Connecticut 06904
MedStar Washington Washington D.C. District of Columbia 20010
The Cardiac and Vascular Institute Gainesville Florida 32605
Emory University Hospital Midtown Atlanta Georgia 30308
Northwestern University Chicago Illinois 60611
Southern Illinois University Springfield Illinois 62794
Ochsner Heart and Vascular Institute New Orleans Louisiana 70121
The Brigham and Women's Hospital Boston Massachusetts 02120
Munson Medical Center Traverse City Michigan 49684
Minneapolis Heart Institute Foundation Minneapolis Minnesota 55407
Saint Luke's Health System Kansas City Missouri 64111
Renown Regional Medical Center Reno Nevada 89502
Deborah Heart & Lung Center Browns Mills New Jersey 08015
Hackensack University Hackensack New Jersey 07601
Columbia University Medical Center/NYPH New York New York 10032
Northwell Health Inc. New York New York 10075
The University of North Carolina at Chapel Hill Chapel Hill North Carolina 27599
Cleveland Clinic Cleveland Ohio 44195
University of Pennsylvania Health System Philadelphia Pennsylvania 19104
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213
Medical University of South Carolina Charleston South Carolina 29425
The University of Tennessee Health Science Center Memphis Tennessee 38163
Vanderbilt University Nashville Tennessee 37232
University of Utah Salt Lake City Utah 84132
Swedish Medical Center Seattle Washington 98122

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 19 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03614260, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 3, 2025 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03614260 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →